Y-mAbs Therapeutics, Inc.

NASDAQ:YMAB

8.28 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016
Operating Activities:
Net Income -21.427-95.568-55.275-119.337-81.028-43.274-19.161-17.057
Depreciation & Amortization 0.7350.8390.7820.3960.1660.02900
Deferred Income Tax 001.897-0.5760000
Stock Based Compensation 14.45325.60319.33416.1374.6571.9660.6090.258
Change In Working Capital -19.734-10.371-7.2843.4442.665-0.0472.7453.353
Accounts Receivables -9.923-4.819-7.712-7.3760000
Inventory 1.637-1.19-5.5127.3760000
Accounts Payables -6.856-0.9194.180.8522.6171.2612.3850.836
Other Working Capital -4.592-3.4431.762.5920.048-1.3080.362.517
Other Non Cash Items -1.2593.577-62.018.7070.0430.097-0.0632.28
Operating Cash Flow -27.232-75.921-102.556-91.231-73.497-41.229-15.87-11.166
Investing Activities:
Investments In Property Plant And Equipment 00-0.967-0.175-1.965-0.23400
Acquisitions Net 00000000
Purchases Of Investments 00000000
Sales Maturities Of Investments 00000000
Other Investing Activites 0062.01-2.610000
Investing Cash Flow 0061.043-2.785-1.965-0.23400
Financing Activities:
Debt Repayment 00000000
Common Stock Issued 0.10.084107.7252.004134.70499.76589.84419.338
Common Stock Repurchased 0000000-0.366
Dividends Paid 00000000
Other Financing Activities 0.10.0840.5892.0040-1.002-0.2580
Financing Cash Flow 0.10.084108.3142.004134.70498.76389.58618.972
Other Information:
Effect Of Forex Changes On Cash 0.0070.0350.129-0.490.0230.056-0.1080
Net Change In Cash -27.125-75.80266.93-92.50259.26557.35673.6087.806
Cash At End Of Period 78.637105.762181.564114.634207.136147.87190.48316.875